Research Articles
SOX9 Transcriptional Networks in Complex Tissues: From Pioneer Functions to Therapeutic Targeting
This article provides a comprehensive analysis of the SOX9 transcriptional network, a master regulator with critical, context-dependent roles in development, homeostasis, and disease.
CRISPR-Mediated SOX9 Editing in Primary Immune Cells: Strategies for Enhancing Efficiency and Therapeutic Application
This article provides a comprehensive guide for researchers and drug development professionals on optimizing SOX9 gene editing in primary immune cells.
Mastering SOX9 Targeting: Strategies to Enhance Specificity in Cancer and Regenerative Therapeutics
This comprehensive review addresses the critical challenge of improving SOX9 target specificity in therapeutic development.
Targeting SOX9 to Overcome Therapy Resistance in Cancer: Mechanisms, Strategies, and Clinical Outlook
The transcription factor SOX9 has emerged as a pivotal driver of therapy resistance across diverse cancer types, including gastric, ovarian, breast, and colorectal cancers.
The Double-Edged Sword: Balancing SOX9 Inhibition in Cancer with Tissue Repair Side Effects
SOX9 inhibition presents a promising therapeutic strategy for overcoming radioresistance and eradicating cancer stem cells in malignancies like gastrointestinal cancer.
SOX9 in Immunotherapy: Unraveling Context-Dependent Roles from Cancer Foe to Repair Ally
The transcription factor SOX9 presents a significant paradox in cancer biology and immunotherapy, acting as both a potent oncogene and a crucial tissue repair factor.
SOX9 Gene Editing in Organoid Models: Unraveling Immune Modulation and Therapeutic Potential
This article explores the convergence of SOX9 gene editing and organoid technology for advanced immune function studies.
Targeting SOX9 in Tumor-Associated Macrophages: A Comprehensive Protocol for Knockdown and Functional Analysis in the Tumor Microenvironment
This article provides a detailed methodological and conceptual framework for researchers aiming to investigate the role of SOX9 in tumor-associated macrophages (TAMs).
Targeting SOX9 to Overcome Resistance to PD-1/PD-L1 Blockade in Cancer
Combining SOX9 inhibition with PD-1/PD-L1 blockade represents a promising strategy to overcome immunotherapy resistance in solid tumors.
Targeting SOX9 in Cancer Immunotherapy: Mechanisms, Inhibition Strategies, and Clinical Outlook
The transcription factor SOX9 emerges as a pivotal, yet dualistic, regulator in cancer biology and tumor immunology.